Potential Beneficial Effects of Resveratrol
|The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.|
|ClinicalTrials.gov Identifier: NCT01150955|
Recruitment Status : Completed
First Posted : June 25, 2010
Last Update Posted : March 22, 2012
|Condition or disease||Intervention/treatment||Phase|
|Metabolic Syndrome Obesity||Dietary Supplement: Resveratrol Other: Placebo||Not Applicable|
|Study Type :||Interventional (Clinical Trial)|
|Actual Enrollment :||24 participants|
|Intervention Model:||Parallel Assignment|
|Masking:||Triple (Participant, Care Provider, Investigator)|
|Primary Purpose:||Basic Science|
|Official Title:||Potential Beneficial Effects of Resveratrol on Obesity, Metabolic Syndrome and Inflammation - Emphasis on Description of the Molecular Biology Underpinning the Interplay Between Calorie Restriction, SIRT1, STAT5 and the GH/IGF-I Axis|
|Study Start Date :||October 2010|
|Actual Primary Completion Date :||November 2011|
|Actual Study Completion Date :||November 2011|
Active Comparator: Resveratrol
Dietary supplement of resveratrol 500 mg three times a day over five weeks.
Dietary Supplement: Resveratrol
500 mg three times a day for five weeks.
Other Name: Fluxome Sciences.
|Placebo Comparator: Placebo||
Placebo (starch capsules) 500 mg three times a day for five weeks.
Other Name: Starch
- Metabolic parameters [ Time Frame: Five weeks ]Regarding glucose, protein and fat metabolism.
- Pathways of substrate metabolism. [ Time Frame: Five weeks ]Description of the biochemical pathways underpinning the interplay between calorie restriction, SIRT1, STAT5 and the GH/IGF-I axis.
To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT01150955
|Aarhus University Hospital, Department of Endocrinology, MEA|
|Aarhus, Denmark, 8000|
|Study Chair:||Jens Otto L Jørgensen, Professor,MD||Aarhus University Hospital|